RYLPF:OTC-Koninklijke Philips N.V (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 25.9971

Change

-0.10 (-0.39)%

Market Cap

USD 23.84B

Volume

169.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

-2.13 (-3.85%)

USD 61.66B
SMMNY Siemens Healthineers AG ADR

-0.49 (-1.82%)

USD 61.36B
SONVF Sonova Holding AG

-0.50 (-0.14%)

USD 22.14B
SNWV SANUWAVE Health Inc

+0.44 (+1.96%)

USD 20.67B
SNNUF Smith & Nephew plc

N/A

USD 12.50B
WILLF Demant A/S

N/A

USD 8.39B
GNGBF Getinge AB

N/A

USD 5.12B
AMBBY Ambu A/S

N/A

USD 5.04B
AMBFF Ambu A/S

N/A

USD 5.04B
GGNDF GN Store Nord A/S

-3.21 (-15.10%)

USD 3.10B

ETFs Containing RYLPF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.82% 69% C- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.82% 69% C- 62% D
Trailing 12 Months  
Capital Gain 28.06% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.06% 70% C- 69% C-
Trailing 5 Years  
Capital Gain -40.58% 52% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.58% 52% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain -5.20% 38% F 28% F
Dividend Return -5.20% 38% F 25% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.42% 75% C 60% D-
Risk Adjusted Return -13.18% 35% F 27% F
Market Capitalization 23.84B 98% N/A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector